Search Results - "Zerbe, Horst"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    The leukotriene receptor antagonist montelukast as a potential therapeutic adjuvant in multiple sclerosis - a review by Pietrantonio, Frank, Serreqi, Alex, Zerbe, Horst, Svenningsson, Per, Aigner, Ludwig

    Published in Frontiers in pharmacology (13-09-2024)
    “…Multiple Sclerosis (MS) is a multifactorial autoimmune disease of the central nervous system (CNS). It is characterized by a heightened activation of the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic by Aigner, Ludwig, Pietrantonio, Frank, Bessa de Sousa, Diana Marisa, Michael, Johanna, Schuster, Daniela, Reitsamer, Herbert Anton, Zerbe, Horst, Studnicka, Michael

    Published in Frontiers in molecular biosciences (17-12-2020)
    “…The emergence and global impact of COVID-19 has focused the scientific and medical community on the pivotal influential role of respiratory viruses as causes…”
    Get full text
    Journal Article
  4. 4

    Improved Bioavailability of Montelukast through a Novel Oral Mucoadhesive Film in Humans and Mice by Michael, Johanna, Bessa de Sousa, Diana, Conway, Justin, Gonzalez-Labrada, Erick, Obeid, Rodolphe, Tevini, Julia, Felder, Thomas, Hutter-Paier, Birgit, Zerbe, Horst, Paiement, Nadine, Aigner, Ludwig

    Published in Pharmaceutics (23-12-2020)
    “…The leukotriene receptor antagonist Montelukast (MTK) is an approved medication for the treatment of asthma and allergic rhinitis. The existing marketed tablet…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Evaluation of pilocarpine-loaded albumin particles as controlled drug delivery systems for the eye. II. Co-administration with bioadhesive and viscous polymers by Zimmer, Annette Katharina, Chetoni, Patricia, Saettone, Marco Fabrizio, Zerbe, Horst, Kreuter, Jo¨rg

    Published in Journal of controlled release (1995)
    “…The aim of the present investigation was to investigate the influence of various polymers at different concentrations on the in vivo activity of…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Isosorbide-5-nitrate sustained-release pellets. An example of computer-supported drug development by ZERBE, H, LUCKOW, V, CAWELLO, W, CORDES, G

    Published in Pharmaceutical research (1985)
    “…To achieve a fast onset and a sufficiently long duration of action in the long-term treatment of angina pectoris a composite dosage form was developed,…”
    Get full text
    Journal Article